Literature DB >> 3875643

Complement proteins and C3 anaphylatoxin in the tears of patients with conjunctivitis.

M Ballow, P C Donshik, L Mendelson.   

Abstract

Previous studies in our laboratory have demonstrated pollen-specific IgG antibodies in the tears of patients with vernal conjunctivitis (VC) and elevated tear IgG levels in patients with contact lens-induced giant papillary conjunctivitis (GPC). Tear secretions were examined for complement (C) proteins to determine the role of this effector system in the pathogenesis of these ocular disorders. The tears of VC (15) and GPC (10) patients with active disease had elevated tear levels of both C3 and factor B. By use of transferrin as a marker for the leakage of plasma proteins into the tears, most C3 was locally produced by the conjunctival tissues. Although immune complexes could not be detected in the tear secretions, increased levels of C3 des Arg were present in the tears that suggested complement activation with the generation of anaphylatoxins. These studies suggest that complement may be important in the inflammatory ocular process of VC and GPC and that the generation of anaphylatoxins (C3a), even by nonimmune mechanisms, may contribute to basophil and mast cell activation with the release of inflammatory mediators into the tear secretions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3875643     DOI: 10.1016/0091-6749(85)90729-8

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  8 in total

1.  Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice.

Authors:  Beatrix Schäfer; Adrian M Piliponsky; Tatsuya Oka; Chang Ho Song; Norma P Gerard; Craig Gerard; Mindy Tsai; Janet Kalesnikoff; Stephen J Galli
Journal:  J Allergy Clin Immunol       Date:  2012-06-22       Impact factor: 10.793

2.  HPLC analysis of tear proteins in giant papillary conjunctivitis.

Authors:  M S Suttorp-Schulten; L Luyendijk; J H Kok; A Kijlstra
Journal:  Doc Ophthalmol       Date:  1989-08       Impact factor: 2.379

3.  N-acetyl-aspartyl glutamic acid (NAAGA) topical eyedrops in the treatment of giant papillary conjunctivitis (GPC).

Authors:  F Meijer; K Pogany; J H Kok; A Kijlstra
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

4.  Giant papillary conjunctivitis.

Authors:  P C Donshik
Journal:  Trans Am Ophthalmol Soc       Date:  1994

5.  Both freshly prepared and frozen-stored amniotic membrane cells express the complement inhibitor CD59.

Authors:  Agnes Füst; Eva Pállinger; Adrienn Stündl; Eszter Kovács; László Imre; Sára Tóth; János Németh
Journal:  ScientificWorldJournal       Date:  2012-05-22

Review 6.  Inhibitors of complement activity in human breast-milk: a proposed hypothesis of their physiological significance.

Authors:  M O Ogundele
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

7.  A novel multiplex detection array revealed systemic complement activation in oral squamous cell carcinoma.

Authors:  Juliane Gallenkamp; Gerrit Spanier; Elisabeth Wörle; Markus Englbrecht; Michael Kirschfink; Roman Greslechner; Regine Braun; Nicole Schäfer; Richard J Bauer; Diana Pauly
Journal:  Oncotarget       Date:  2017-12-06

8.  Proteomic analysis of human lacrimal and tear fluid in dry eye disease.

Authors:  Jae Hun Jung; Yong Woo Ji; Ho Sik Hwang; Jae Won Oh; Hyun Chang Kim; Hyung Keun Lee; Kwang Pyo Kim
Journal:  Sci Rep       Date:  2017-10-17       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.